Perform testing in support of PFIZER pre-clinical anti-SARS-CoV-2 mAb program as directed by PFIZER

Project: Research project

Project Details

StatusActive
Effective start/end date12/7/223/7/25

Funding

  • Pfizer, Inc.: $1,144,800.00